Form 4/A for NEO NEOGENOMICS INC
Accepted 2025-06-03 00:00:00 ET · period of report 2025-06-01 · accession 0001077183-25-000132 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2025-06-03 | 2025-06-01 | NEO | HANNAH ALISON L. | Dir | M - OptEx | $0.00 | +12.3K | 131.0K | +10% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-06-01 | M | A | 12,254 | $0.00 | 131,023 | D | — | — | (F2) As reported in the original Form 4, reflects the release of restricted stock units that were previously reported on a Form 4. |